Literature DB >> 28891076

Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.

Yuko Ehara1, Osamu Yamamoto1, Kenjiro Kosaki2, Yuichi Yoshida1.   

Abstract

Neurofibromatosis 1 (NF1) is characterized by cutaneous, neurological and osseous manifestations. Most NF1 patients develop cutaneous neurofibromas. However, time-dependent change with aging and the predilection site of cutaneous neurofibromas remain unclear. To clarify the natural course and characteristics of cutaneous neurofibromas, a retrospective study was conducted for 57 NF1 patients who were treated at the Department of Dermatology of Tottori University Hospital between January 2007 and April 2016. For each patient, we investigated the time-dependent changes and the numbers of cutaneous neurofibromas in four body surface regions. There was a positive correlation between age and number of cutaneous neurofibromas (r = 0.75, P < 0.001). Cutaneous neurofibromas were located on the trunk (60.2%), lower limbs (16.1%), upper limbs (14.4%), and head and neck (9.2%). There was no significant relationship between each body type (e.g. obese or thin) and cutaneous neurofibromas. With respect to the year-to-year percentage change in cutaneous neurofibromas, the average annual rate of increase was 0.21 (range, -0.71 to 1.2). The number of cutaneous neurofibromas had increased in approximately 61% of the patients 1 year later. Our data will enable physicians to estimate the overall state of cutaneous neurofibromas in NF1 and will be useful for handling cutaneous manifestations before they become a serious condition.
© 2017 Japanese Dermatological Association.

Entities:  

Keywords:  NF1; cutaneous neurofibroma; distribution; neurofibromatosis 1; predilection body site

Mesh:

Year:  2017        PMID: 28891076     DOI: 10.1111/1346-8138.14025

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.

Authors:  Gaku Tsuji; Ayako Takai-Yumine; Takahiro Kato; Masutaka Furue
Journal:  Cell Death Dis       Date:  2021-05-19       Impact factor: 8.469

2.  Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.

Authors:  Alessandro Stella; Patrizia Lastella; Daria Carmela Loconte; Nenad Bukvic; Dora Varvara; Margherita Patruno; Rosanna Bagnulo; Rosaura Lovaglio; Nicola Bartolomeo; Gabriella Serio; Nicoletta Resta
Journal:  Genes (Basel)       Date:  2018-04-17       Impact factor: 4.096

3.  Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.

Authors:  Nicolas Ortonne; Steven L Carroll; Fausto J Rodriguez; Douglas C Miller; Rosalynn M Nazarian; Jaishri O Blakeley; Zachary B Madaj; Sharad K Verma; Anat Stemmer-Rachamimov
Journal:  Neurooncol Adv       Date:  2019-12-05

4.  Two cases of debulking surgery for lower limb diffuse plexiform neurofibroma with transcatheter arterial embolisation.

Authors:  Daiki Kitano; Takeo Osaki; Mika Nakasone; Tadashi Nomura; Kazunobu Hashikawa; Hiroto Terashi
Journal:  Int J Surg Case Rep       Date:  2019-01-29

5.  Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.

Authors:  Sheilagh Maguiness; Yemima Berman; Nathan Rubin; Melissa Dodds; Scott R Plotkin; Claire Wong; Christopher Moertel
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.